ADARx Pharmaceuticals, Inc. ADRX
12.79 USD -1.37 (-9.68%)
Regular-session close
12.79 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
12.66 Day range 14.86
12.79 52-week range 20.64
- YTD
- -33.90%
- 1 year
- -33.90%
Held by funds
22 US ETFs and mutual funds hold ADRX · largest positions
- FCNTX 0.01% of fund $9.33M
- FSPHX 0.12% of fund $7.98M
- FBGRX 0.01% of fund $6.54M
- FGCKX 0.01% of fund $6.23M
- SHSSX 0.10% of fund $6.12M
- FHCIX 0.12% of fund $4.15M
- FBTTX 0.11% of fund $2.52M
- VEXRX 0.01% of fund $1.77M
- FNITX 0.01% of fund $1.55M
- FBIOX 0.01% of fund $743.56K
- BILPX 0.02% of fund $654.07K
- VTI 0.00% of fund $611.06K
- FWWFX 0.01% of fund $251.24K
- VXF 0.00% of fund $233.32K
- VTWO 0.00% of fund $79.84K
- TMED 0.13% of fund $49.09K
- TDNA 0.16% of fund $18.75K
- VBINX 0.00% of fund $10.39K
- VITPX 0.00% of fund $9.25K
- VTWG 0.00% of fund $8.02K
Ownership
Held by insiders 40.13%
Held by institutions 82.92%
Float held by institutions 138.49%
Institutions 79
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 21.77% | 24,205,789 | 308.38M | Sep 29, 2026 |
| SR One Capital Management, LP | 8.94% | 9,936,661 | 126.59M | Sep 29, 2026 |
| Bain Capital Life Sciences Investors, LLC | 6.05% | 6,728,970 | 85.73M | Sep 29, 2026 |
| TCG Crossover Management, LLC | 3.70% | 4,116,452 | 52.44M | Sep 29, 2026 |
| FMR, LLC | 3.28% | 3,646,090 | 46.45M | Sep 29, 2026 |
| Price (T.Rowe) Associates Inc | 2.60% | 2,894,396 | 36.87M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 2.92% | 3,246,801 | 41.36M | Sep 29, 2026 |
| Fidelity Contrafund | 0.42% | 467,700 | 5.96M | Sep 29, 2026 |
| AB CAP FUND, INC.-AB Small Cap Growth Portfolio | 0.39% | 430,729 | 5.49M | Sep 29, 2026 |
| AB DISCOVERY GROWTH FUND, INC. | 0.38% | 427,316 | 5.44M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 0.36% | 400,000 | 5.10M | Sep 29, 2026 |
| Fidelity Securities Fund-Fidelity Blue Chip Growth Fund | 0.30% | 328,200 | 4.18M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHIMOVITS EREZ | Director | Purchase | Sep 27, 2026 | 0 |
| GEORGE SIMEON J. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| GORDON CARL L | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| LAV BIOSCIENCES FUND V LP | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 27, 2026 | 0 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
| SR ONE CAPITAL MANAGEMENT, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Sep 27, 2026 | 0 |
